Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Breast Neoplasms 1484Neoplasms 1101Carcinoma, Non-Small-Cell Lung 918Prostatic Neoplasms 802Multiple Myeloma 586Colorectal Neoplasms 535Leukemia, Myeloid, Acute 505Lung Neoplasms 489Lymphoma 455Melanoma 454Neoplasm Metastasis 451Lymphoma, Non-Hodgkin 416Leukemia 409Leukemia, Lymphocytic, Chronic, B-Cell 366Ovarian Neoplasms 357Pancreatic Neoplasms 338Precursor Cell Lymphoblastic Leukemia-Lymphoma 334Recurrence 315Head and Neck Neoplasms 298Lymphoma, Follicular 297Myelodysplastic Syndromes 282Carcinoma, Renal Cell 272Glioblastoma 266Brain Neoplasms 265Hodgkin Disease 260Lymphoma, Large B-Cell, Diffuse 255Carcinoma, Hepatocellular 241Lymphoma, Mantle-Cell 219Squamous Cell Carcinoma of Head and Neck 214Stomach Neoplasms 210

Interventions

Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Risk Reduction Behavior × Clear all
NCT03985852 2025-09-22

BRIDGE

University of Utah

Phase NA Completed
3,073 enrolled 7 charts

Neoplasms, Risk Reduction Behavior

NCT03346200 2025-03-07

KARISMA2

Karolinska Institutet

Phase 2 Completed
1,440 enrolled 14 charts
Breast

Breast Neoplasms, Risk Reduction Behavior

NCT03315286 2019-12-18

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Weill Medical College of Cornell University

Phase NA Completed
111 enrolled 13 charts
Dermatologic

Skin Neoplasms, Health Behavior, Risk Reduction Behavior, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡